Profile
ACOR TAK ZTS HLN TEVA VTRS
Company Name Acorda Therapeutics, Inc. Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $821.03K $56.52B $56.15B $49.48B $39.78B $14.94B
Employees 0.10K 49.28K 13.80K 24.56K 37.00K 32.00K
CEO Ron Cohen Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
ACOR TAK ZTS HLN TEVA VTRS
Quant Rating Score 3 3 3 4 3 2
Quant Rating Neutral Neutral Neutral Buy Neutral Sell
Trading
ACOR TAK ZTS HLN TEVA VTRS
Last Close $0.661 $14.14 $118.8 $9.68 $24.59 $10.66
High 52 $0.66 $15.52 $178.71 $11.41 $25.83 $13.37
Low 52 $0.66 $12.89 $118.8 $8.73 $12.82 $7.26
Price vs. 52 Week High 0.15 % -8.89 % -33.52 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 0.15 % 9.7 % 0 % 10.88 % 91.81 % 46.83 %
Total Return
ACOR TAK ZTS HLN TEVA VTRS
1 Month Return 0 % 0.71 % -17.53 % 2.11 % 27.34 % 4.82 %
3 Month Return 0 % -6.73 % -21.96 % -0.05 % 36.16 % 0.28 %
6 Month Return 0 % 0.21 % -27.13 % -10.37 % 45.16 % 20.59 %
9 Month Return 0 % 1.73 % -24.08 % -3.1 % 48.4 % -1.84 %
YTD Return 0 % 6.8 % -27.09 % 1.47 % 11.57 % -14.38 %
1 Year Return 0 % 3.82 % -32.33 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACOR TAK ZTS HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 3.6 % 1.59 % 1.41 % - 3.7 %
Dividend Paid and Capex Coverage Ration (TTM) -52.97 % 2.23 % 1.89 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 198 % 2.03 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 277.04 % 32.55 % 27.27 % - -15.34 %
Growth
ACOR TAK ZTS HLN TEVA VTRS
Asset Growth -70.24 % -0.34 % 0.76 % 3.61 % -12.97 %
Gross Profit Growth -18.87 % 9.63 % -0.19 % 10.86 % -12.66 %
Revenue Growth -0.79 % 8.33 % -0.61 % 4.32 % -4.46 %
Revenue 3 Year -74.97 % 24.31 % 19.01 % 11.71 % -16.52 %
Revenue 5 Year -92.13 % 55.65 % 33.95 % -1.27 % -39.86 %
Revenue 10 Year -90.22 % 113.39 % 33.95 % -34.65 % -36.45 %
EBIT Growth -3382.25 % 5.67 % 13.52 % -9.52 % -109.43 %
Net Income Growth -283.6 % 6.06 % 37.46 % 185.97 % -1259.41 %
Net Income 3 Yeari Growth Per Share 17.38 % 27.46 % 4.91 % 155.65 % 49.38 %
Net Income 5 Yeari Growth Per Share -336.79 % 74.46 % 122.63 % 133.65 % -1871.56 %
Net Income 10 Yeari Growth Per Share -530.12 % 370.4 % 122.63 % -33.98 % -122.71 %
Operating Income Growth 44.66 % 10.52 % 10.52 % 1131.35 % -98.68 %
Operating Cash Flow Growth (CFG) 33.17 % 25.5 % 9.57 % -35.33 % -17.74 %
Operating 3 Year CFG 92.54 % 39.36 % 71.6 % 0.19 % -22.68 %
Operating 5 Year CFG -102.93 % 73.18 % 196.04 % 29.24 % -40.08 %
Operating 10 Year CFG -109.96 % 420.39 % 196.04 % -77.86 % -24.47 %
EPS Growth -204.32 % 7.68 % 33.33 % 184.83 % -1262.28 %
EPS Diluted Growth -204.32 % 7.89 % 33.33 % 182.76 % -1269.98 %
Book Value Per Share -233.85 % -2.96 % -1.63 % 36.19 % -8.42 %
Share Holder 3 Year Equity Growth Per Share -121.6 % 9.65 % -37.97 % -2.08 % -7.88 %
Share Holder 5 Year Equity Growth Per Share -108.14 % 85.42 % -40.16 % -24.81 % -26.41 %
Share Holder 10 Year Equity Growth Per Share -110.03 % 301.38 % -40.16 % -80.23 % 90.51 %
Dividend Per Share Growth - 15.33 % 49.01 % - 0.45 %
Dividend 3 Year Growth Per Share - 73.18 % -49.79 % - 45.93 %
Dividend 5 Year Growth Per Share -100 % 163.51 % -49.97 % - -
Dividend 10 Year Growth Per Share - 493.89 % -49.97 % -100 % -
Debt Growth 10.4 % -0.16 % 6.83 % -3.86 % -22.13 %
Free Cash Flow Growth 32.35 % 41.76 % 16.27 % -43.99 % -14.98 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2024 31 Dec 2025 31 Dec 2024
Profitability
ACOR TAK ZTS HLN TEVA VTRS
Gross Profit Margin TTM 60.86 % 59.49 % 70.63 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM -214.75 % 0.73 % 17.49 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM 786.07 % 1.58 % 53.56 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM 21.14 % 3.59 % 26.48 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 85.42 % 54.99 % 79.59 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 1272.44 % 44.75 % 94.2 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM -19.78 % 10.28 % 37.63 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM -7.33 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 6.8 5.89 6.1 5.14 4.68 3.94
Payables Turnover TTM 3.17 3.87 6.73 1.18 3.31 6.81
Inventory Turnover TTM 2.85 1.29 1.12 3.72 2.63 2.2
Fixed Asset Turnover TTM 1867.19 % 214.23 % 241.44 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 99.9 % 28.97 % 61.99 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM -11.26 710.55 6.58 0.11 1.76 1.7
Free Cash Flow Per Share TTM -11.47 589.53 5.06 0.1 1.32 1.37
Cash Per Share TTM 2444.44 % 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM -11.89 % 25.14 % 31.03 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.89 % 82.97 % 76.82 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM -7.33 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM -0.06 9.34 25.07 38.08 25.95 9.34
Price To Operating Cash Flows Ratio TTM -0.06 7.75 19.35 35.1 19.5 7.62
Price Cash Flow Ratio TTM -0.06 7.75 19.35 35.1 19.5 7.62
Income Statement (TTM)
ACOR TAK ZTS HLN TEVA VTRS
Revenue $0.12B $4581.55B $9.26B $11.23B $17.26B $14.74B
Gross Profit $0.07B $3001.33B $6.4B $6.95B $8.94B $5.62B
Gross Profit Ratio 60.86% 65.51% 69.1% 61.85% 51.79% 38.15%
EBITDA $-0.2B $1210.51B $3.87B $2.51B $3.14B $2.82B
Net Income $-0.25B $107.93B $2.49B $1.44B $1.41B $-0.63B
EPS Diluted -203.59 33.62 5.47 0.32 1.2 -0.53
Balance Sheet (MRQ)
ACOR TAK ZTS HLN TEVA VTRS
Long Term Debt $0B $3966.33B $5.39B $8.62B $15.56B $14.22B
Total Liabilities $0.28B $7312.37B $9.47B $18.09B $32.83B $22.87B
Total Equity $-0.16B $6935.98B $4.77B $16.22B $7.91B $18.64B
Total Investments $0B $382.4B $0.03B $0.14B $0B $1.7B
Total Debt $0.19B $4515.27B $6.74B $10.1B $17.38B $14.31B
Total Assets $0.12B $14248.34B $14.24B $34.32B $40.75B $41.5B
Cash Flow Statement (TTM)
ACOR TAK ZTS HLN TEVA VTRS
Net Income $-0.25B $107.93B $2.5B $1.44B $1.42B $-0.63B
Inventory $-0B $-34.97B $-0.04B $0.22B $0.15B $-0.72B
Dividends Paid $0B $-302.5B $-0.79B $-0.57B $0B $-0.57B
Operating Cash Flow $-0.01B $1057.18B $2.95B $2.3B $1.65B $2.3B
Capital Expenditure $-0B $-200.8B $-0.66B $-0.25B $-0.5B $-0.33B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.585
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.9495
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 5.07
ALVOW Alvotech 0.4511
AMPH Amphastar Pharmaceuticals, Inc. 28.6
AMRX Amneal Pharmaceuticals, Inc. 14.437
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 79.055
APUS Apimeds Pharmaceuticals US, Inc 1.5613
AQST Aquestive Therapeutics, Inc. 3.92
ASRT Assertio Holdings, Inc. 12.08
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.64
AYTU Aytu BioPharma, Inc. 2.34
ETFs With Exposure to ACOR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 342.925
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00001 152.025
VXF Vanguard Extended Market Index Fund 0 219.56
VSTCX Vanguard Strategic Small-Cap Equity Fund Investor Shares 0 45.33
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0 34.1348
VTSAX Vanguard Total Stock Market Index Fund 0 166.03
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 165.43
VITSX Vanguard Total Stock Market Index Fund 0 166.06
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 165.44
VEMPX Vanguard Extended Market Index InstlPlus 0 408.25
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 311.51
Unlock